Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GenVec appoints chief medical officer

Executive Summary

Thomas Davis named to the post of chief medical officer at GenVec. Davis was previously the head of the hematologic malignancies portfolio for the Cancer Therapeutics Evaluation Program at the National Cancer Institute. He will oversee clinical development of the company's gene-based product candidates. FDA placed GenVec's oncologic TNFerade on clinical hold last October after Phase II trial data revealed a potential increased risk of blood clots...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS046148

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel